摘要
循环肿瘤细胞(CTCs)有明显的诊断潜力因为可以反映多种癌症的存在和复发。然而,这种潜力仍然是有限的,缺乏强大的和可得到的隔离技术。替代隔离可能是他们的直接检测,其中包括其他外周血细胞,这将需要标记物,使他们可以区分于一个非常高的背景信号。审查评估的Hox基因的潜在作用,一系列的同源域包括在胚胎发育和肿瘤发生中的关键作用域,作为独特的和可能的疾病和特定的标记。
关键词: 循环肿瘤细胞,Hox基因,生物标志物。
Current Molecular Medicine
Title:HOX Genes as Potential Markers of Circulating Tumour Cells
Volume: 16 Issue: 4
Author(s): R. Morgan, M. El-Tanani
Affiliation:
关键词: 循环肿瘤细胞,Hox基因,生物标志物。
摘要: Circulating tumour cells (CTCs) have significant diagnostic potential as they can reflect both the presence and recurrence of a wide range of cancers. However, this potential continues to be limited by the lack of robust and accessible isolation technologies. An alternative to isolation might be their direct detection amongst other peripheral blood cells, although this would require markers that allow them to be distinguished from an exceptionally high background signal. This review assesses the potential role of HOX genes, a family of homeodomain containing transcription factors with key roles in both embryonic development and oncogenesis, as unique and possibly disease specific markers of CTCs.
Export Options
About this article
Cite this article as:
R. Morgan, M. El-Tanani , HOX Genes as Potential Markers of Circulating Tumour Cells, Current Molecular Medicine 2016; 16 (4) . https://dx.doi.org/10.2174/1566524016666160316145715
DOI https://dx.doi.org/10.2174/1566524016666160316145715 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Current Medicinal Chemistry Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
Current Cancer Drug Targets Cancer-Type Organic Anion Transporting Polypeptide 1B3: Current Knowledge of the Gene Structure, Expression Profile, Functional Implications and Future Perspectives
Current Drug Metabolism Anticancer Metallotherapeutics in Preclinical Development
Current Medicinal Chemistry Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer’s Model
CNS & Neurological Disorders - Drug Targets Current Targets for Anticancer Drug Discovery
Current Drug Targets Drug Analogs of COX-2 Selective Inhibitors Lumiracoxib and Valdecoxib Derived from in silico Search and Optimization
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design Squalamine as an Example of a New Potent Antimicrobial Agents Class: A Critical Review
Current Medicinal Chemistry Primary Tumors of the Sacrum: Imaging Findings
Current Medical Imaging Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery FRET Based Ratio-Metric Sensing of Hyaluronidase in Synthetic Urine as a Biomarker for Bladder and Prostate Cancer
Current Pharmaceutical Biotechnology MicroRNAs Regulate the Epithelial to Mesenchymal Transition (EMT) in Cancer Progression
MicroRNA Nanotechnology in Therapeutics – Current Technologies and Applications
Current Nanoscience Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Current Gene Therapy Specific Hemosiderin Deposition in Spleen Induced by a Low Dose of Cisplatin: Altered Iron Metabolism and Its Implication as an Acute Hemosiderin Formation Model
Current Drug Metabolism Novel Concepts in the Development of Platinum Antitumor Drugs
Current Medicinal Chemistry - Anti-Cancer Agents